Can Helicobacter pylori infection and long-term PPI therapy reduce B12/folate absorption and raise homocysteine levels?

Helicobacter pylori infection and the long-term use of proton pump inhibitors (PPIs) are both established factors that can disrupt gastric physiology, leading to impaired micronutrient absorption and subsequent metabolic imbalances.

Clinical effectiveness and evidence

Research confirms that H. pylori–associated gastritis is significantly linked to lower serum levels of both vitamin B12 and folate.

• H. pylori Impact: A meta-analysis of 48 studies demonstrated that patients positive for H. pylori have significantly lower concentrations of these vitamins compared to uninfected individuals. Eradication of the bacteria has been shown to successfully increase B12 levels and lower homocysteine, establishing a clear link.
• PPI Impact: The evidence for PPIs is most robust regarding vitamin B12. While some recent meta-analyses show varied results, several systematic reviews indicate a 12–18% reduction in B12 levels among long-term users, with some observational data showing a 2.41-fold increased risk of deficiency. The evidence for PPIs reducing folate is theoretically possible due to pH changes but lacks strong clinical confirmation in current meta-analyses.

Mechanistic explanations

The elevation of homocysteine in these conditions is driven by specific physiological and biochemical disruptions:

• Achlorhydria and Atrophy: H. pylori causes chronic inflammation that can lead to gastric atrophy and the destruction of parietal cells. This results in decreased hydrochloric acid (hypochlorhydria) and reduced Intrinsic Factor (IF). PPIs similarly induce hypochlorhydria by inhibiting the H+/K+ ATPase enzyme.
• B12 Release: Hydrochloric acid is essential for releasing vitamin B12 from dietary proteins. Without it, B12 remains protein-bound and cannot bind to IF for absorption in the ileum.
• The Remethylation Pathway: Vitamin B12 and folate are critical for the enzyme methionine synthase, which converts homocysteine back into methionine. B12 acts as a cofactor, while folate serves as the methyl donor.
• The Folate Trap: A deficiency in B12 can cause folate to become metabolically "trapped" in an unusable form (5-methyltetrahydrofolate), further blocking the clearance of homocysteine and leading to its accumulation in the blood (hyperhomocysteinemia).

Bottom line

The claim is strongly supported for H. pylori and plausible for long-term PPI use. Both conditions impair the gastric environment necessary for vitamin B12 (and potentially folate) absorption, which directly causes elevated homocysteine by disrupting the essential remethylation cycle.